All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
This disclosure generally relates to dialysis systems. More specifically, this disclosure relates to dialysis systems that include many features that reduce the need for technician involvement in the preparation and administration of dialysis treatment.
There are, at present, hundreds of thousands of patients in the United States with end-stage renal disease. Most of those require dialysis to survive. Many patients receive dialysis treatment at a dialysis center, which can place a demanding, restrictive and tiring schedule on a patient. Patients who receive in-center dialysis typically must travel to the center at least three times a week and sit in a chair for 3 to 4 hours each time while toxins and excess fluids are filtered from their blood. After the treatment, the patient must wait for the needle site to stop bleeding and blood pressure to return to normal, which requires even more time taken away from other, more fulfilling activities in their daily lives. Moreover, in-center patients must follow an uncompromising schedule as a typical center treats three to five shifts of patients in the course of a day. As a result, many people who dialyze three times a week complain of feeling exhausted for at least a few hours after a session.
Many dialysis systems on the market require significant input and attention from technicians prior to, during, and after the dialysis therapy. Before therapy, the technicians are often required to manually install patient blood tubing sets onto the dialysis system, connect the tubing sets to the patient, and to the dialyzer, and manually prime the tubing sets to remove air from the tubing set before therapy. During therapy, the technicians are typically required to monitor venous pressure and fluid levels, and administer boluses of saline and/or heparin to the patient. After therapy, the technicians are often required to return blood in the tubing set to the patient and drain the dialysis system. The inefficiencies of most dialysis systems and the need for significant technician involvement in the process make it even more difficult for patients to receive dialysis therapy away from large treatment centers.
Given the demanding nature of in-center dialysis, many patients have turned to home dialysis as an option. Home dialysis provides the patient with scheduling flexibility as it permits the patient to choose treatment times to fit other activities, such as going to work or caring for a family member. Unfortunately, current dialysis systems are generally unsuitable for use in a patient's home. One reason for this is that current systems are too large and bulky to fit within a typical home. Current dialysis systems are also energy-inefficient in that they use large amounts of energy to heat large amounts of water for proper use. Although some home dialysis systems are available, they generally use complex flow-balancing technology that is relatively expensive to manufacture and most systems are designed with a system of solenoid valves that create high noise levels. As a result, most dialysis treatments are performed at dialysis centers.
A method of achieving dynamic balancing with a dialysis system is provided, comprising operating a blood pump to move a flow of blood from a patient through a patient tubing set and a blood-side of a dialyzer, operating a first dialysate pump and a second dialysate pump to move a flow of dialysate through a dialysate-side of the dialyzer, bypassing the flow of dialysate through the dialysate-side of the dialyzer, and while the flow of dialysate through the dialysate-side of the dialyzer is bypassed, measuring a dialysate pressure between the first dialysate pump and the second dialysate pump, and adjusting a pump speed of the second dialysate pump until the measured dialysate pressure stabilizes.
In some embodiments, the method further comprises resuming the flow of dialysate through the dialysate-side of the dialyzer.
In other embodiments, no fluid passes from the blood-side of the dialyzer to the dialysate-side of the dialyzer when the flow of dialysate resumes through the dialysate-side of the dialyzer.
A method of achieving dynamic balancing with a dialysis system is also provided, comprising operating a blood pump to move a flow of blood from a patient through a patient tubing set and a blood-side of a dialyzer, measuring a venous pressure of the patient, operating a first dialysate pump and a second dialysate pump to move a flow of dialysate through a dialysate-side of the dialyzer, preventing a flow of dialysate from passing through the dialysate-side of the dialyzer, while the flow of dialysate through the dialysate-side of the dialyzer is prevented, measuring a dialysate pressure between the first dialysate pump and the second dialysate pump, and adjusting a pump speed of the second dialysate pump until the measured dialysate pressure stabilizes, allowing the flow of dialysate to pass through the dialysate-side of the dialyzer, and adjusting a pump speed of the second dialysate pump to create a flow imbalance between the first and second dialysate pumps that results in a flow of fluid between the blood-side of the dialyzer and the dialysate-side of the dialyzer to equalize the flow imbalance.
In one embodiment, the flow of fluid travels from the blood-side of the dialyzer to the dialysate-side of the dialyzer.
In another embodiment, the flow of fluid travels from the dialysate-side of the dialyzer to the blood-side of the dialyzer.
In some embodiments, the method further comprises further adjusting the pump speed of the second dialysate pump to calibrate for a pressure loss between the blood-side of the dialyzer and the dialysate-side of the dialyzer.
In other embodiments, the method further comprises repeating the preventing, measuring, and adjusting steps if the measured venous pressure changes by a predetermined threshold.
In one embodiment, the predetermined threshold comprises more than 30 mmHg.
A dialysis system is provided, comprising a blood pump configured to move a flow of blood from a patient through a patient tubing set and a blood-side of a dialyzer, a venous pressure sensor configured to measure a venous pressure of the patient, a first pump and a second pump configured to control the flow of dialysate through a dialysate-side of the dialyzer, one or more valves configured to bypass the dialysate-side of the dialyzer to prevent the flow of dialysate from passing through the dialysate-side of the dialyzer, a dialysate pressure sensor disposed between the first and second pumps and configured to measure a dialysate pressure when the dialysate-side of the dialyzer is bypassed, and an electronic controller operatively coupled to the blood pump, the venous pressure sensor, the first and second pumps, the one or more valves, and the dialysate pressure sensor, the electronic controller configured to adjust a pump speed of the first and second pumps to create a flow imbalance between the first and second pumps that results in a flow of fluid between the blood-side of the dialyzer and the dialysate-side of the dialyzer to equalize the flow imbalance.
A dialysis system is provided, comprising a dialyzer comprising a blood-side and a dialysate-side, a blood circuit coupled to the blood-side of the dialyzer and further comprising a venous line adapted to be connected to an venous connection site of a patient and an arterial line adapted to be connected to an arterial connection site of the patient, a blood pump coupled to the blood circuit and configured to move blood from the patient, through the arterial line, through the blood-side of the dialyzer, and through the venous line back into the patient, a venous pressure sensor coupled to the blood circuit and configured to measure a venous pressure of the patient, a dialysate circuit coupled to the dialysate-side of the dialyzer and further comprising a dialysate line coupled to a dialysate source, an actuator coupled to the dialysate circuit, the actuator comprising a first configuration in which dialysate moves through the dialysate-side of the dialyzer and a second configuration in which dialysate is prevented from moving through the dialysate-side of the dialyzer, a first dialysate pump and a second dialysate pump coupled to the dialysate circuit and configured to move dialysate from the dialysate source, through the dialysate line, and through the dialysate-side of the dialyzer when the actuator is in the first configuration, a dialysate pressure sensor coupled to the dialysate circuit and configured to measure a pressure of the dialysate between the first dialysate pump and the second dialysate pump, an electronic controller operatively coupled to the blood pump, the venous pressure sensor, the dialysate pressure sensor, the actuator, the first dialysate pump, and the second dialysate pump, the electronic controller being configured to achieve dynamic balancing of fluid flow across the dialyzer during dialysis therapy by performing the steps of adjusting a pump speed of the first dialysate pump to move a flow of dialysate through the dialysate-side of the dialyzer, controlling the actuator to prevent the flow of dialysate from moving through the dialysate-side of the dialyzer, receiving the measured dialysate pressure from the dialysate pressure sensor, and adjusting a pump speed of the second dialysate pump until the measured dialysate pressure stabilizes, controlling the actuator to allow the flow of dialysate to move through the dialysate-side of the dialyzer, and adjusting a pump speed of the second dialysate pump to create a flow imbalance between the first and second dialysate pumps that results in a flow of fluid between the blood-side of the dialyzer and the dialysate-side of the dialyzer to equalize the flow imbalance.
In some embodiments, the electronic controller is configured to receive the measured venous pressure from the venous pressure sensor, and is configured to repeat the controlling, receiving, and adjusting steps if the measured venous pressure changes by a predetermined threshold.
A method of connecting a disposable cartridge and tubing set to a dialysis system is provided, comprising the steps of positioning alignment features of the disposable cartridge and tubing set next to alignment features of the dialysis system, and mounting the disposable cartridge and tubing set onto the dialysis system to acoustically couple a venous drip chamber of the disposable cartridge and tubing set with one or more fluid level sensors of the dialysis system.
In some embodiments, the method further comprises measuring a fluid level within the venous drip chamber with the one or more fluid level sensors.
A disposable cartridge adapted to be mounted onto a dialysis system is provided, comprising a frame having a plurality of alignment features configured to removably mate with corresponding alignment features on the dialysis system, a tubing set disposed in the frame, and a venous drip chamber disposed in the frame and connected to the tubing set, the venous drip chamber being positioned within the frame such that it is acoustically coupled to one or more fluid level sensors of the dialysis system when the frame is mounted onto the dialysis system.
A method of priming a tubing set and a dialyzer of a dialysis system is also provided, comprising the steps of operating a blood pump of the dialysis system in a first operating mode to move saline from a saline source into the tubing set and through a blood-side of the dialyzer in a first direction to remove air from the tubing set and the blood-side of the dialyzer, and operating the blood pump in a second operating mode to move at least a portion of the saline through the blood-side of the dialyzer in a second direction opposite to the first direction and out of the tubing set.
In some embodiments, the method further comprises monitoring a fluid level of the saline in a venous drip chamber of the tubing set, and stopping operation of the blood pump in the first operating mode when the fluid level in the venous drip chamber stabilizes or when air no longer circulates through the tubing set.
In one embodiment, operating the blood pump in the first operating mode further comprises moving at least a portion of the saline into a venous drip chamber of the tubing set before moving the saline through the blood-side of the dialyzer.
In another embodiment, operating the blood pump in the second operating mode further comprises moving at least a portion of the saline through the blood-side of the dialyzer before moving the saline through a venous drip chamber of the tubing set.
In some embodiments, the method further comprises operating a dialysate pump to move dialysate from a dialysate source through a dialysate-side of the dialyzer in the first direction to remove air from the dialysate-side of the dialyzer.
In some embodiments, air is removed from the dialysate-side of the dialyzer without physically manipulating an orientation of the dialyzer.
In other embodiments, air is removed from the dialysate-side of the dialyzer without flipping an orientation of the dialyzer.
In some embodiments, the method further comprises opening one or more valves of the dialysis system with an electronic control to allow the saline to move from the saline source into the tubing set.
In one embodiment, the operating the blood pump steps further comprise operating the blood pump with an electronic controller of the dialysis system.
In other embodiments, the saline is moved out of the tubing set through a union joint that attaches a venous line of the tubing set to an arterial line of the tubing set.
In some embodiments, a predetermined volume of saline is moved through the union joint before the dialysis therapy can begin.
A method of returning blood in a patient tubing set of a dialysis delivery system to a patient after a dialysis treatment is provided, comprising activating a blood pump coupled to the patient tubing set to draw saline into the patient tubing set and push blood back into the patient, tracking the number of revolutions of the blood pump to determine the amount of saline drawn into the patient tubing set, and de-activating the blood pump when a predetermined volume of saline is drawn into the patient tubing set.
In some embodiments, the predetermined volume comprises 300-500 ml.
In some embodiments, the method further comprises opening one or more pinch valves of the dialysis delivery system to create a pathway between a saline source and the tubing set.
In additional embodiments, the method further comprises opening one or more pinch valves to create the pathway between the saline source and the tubing set at or adjacent to a patient arterial access site.
In some embodiments, blood is pushed back into the patient through a patient venous access site.
A method of draining fluid out of a dialyzer of a dialysis system after a dialysis treatment is provided, comprising closing a venous line of a patient tubing set of the dialysis system, and operating a pump coupled to the patient tubing set to pull fluid from a dialysate-side of the dialyzer into a blood-side of the dialyzer and out of the dialyzer into a waste container.
In some embodiments, the waste container comprises a saline bag.
In other embodiments, the fluid is pulled through microtube walls of the dialyzer to move the fluid from the dialysate-side of the dialyzer to the blood-side of the dialyzer.
In additional embodiments, the fluid is pulled from the dialyzer against gravity.
A method of controlling a fluid level in a venous drip chamber of a dialysis system during therapy is provided, comprising the steps of generating a flow of blood through a patient tubing set and the venous drip chamber, monitoring a fluid level of the blood in the venous drip chamber with first and second sensors, automatically pumping or venting air out of the venous drip chamber if the fluid level dips below the first sensor, and automatically pumping air into the venous drip chamber if the fluid level rises above the second sensor.
A method of controlling a fluid level in a venous drip chamber of a dialysis system during therapy is provided, comprising the steps of generating a flow of blood through a patient tubing set and the venous drip chamber, monitoring a fluid level of the blood in the venous drip chamber with a sensor, automatically pumping or venting air out of the venous drip chamber if the sensor detects the fluid level dropping below a lower fluid level threshold, automatically pumping air into the venous drip chamber if the sensor detects the fluid level rising above an upper fluid level threshold.
A method of controlling a fluid level in a venous drip chamber of a dialysis system during therapy is provided, comprising the steps of generating a flow of blood through a patient tubing set and the venous drip chamber, monitoring a fluid level of the blood in the venous drip chamber with first and second sensors, and automatically maintaining the fluid level of the blood in the venous drip chamber by pumping or venting air out of the venous drip chamber if the first sensor detects the fluid level dropping below a lower threshold and pumping air into the venous drip chamber if the second sensor detects the fluid level rising above an upper threshold.
A dialysis system is provided, comprising a venous drip chamber configured to remove air from blood flowing therethrough, at least one sensor configured to monitor a fluid level of blood in the venous drip chamber, a pump coupled to the venous drip chamber and configured to pump air into or out of the venous drip chamber, and an electronic controller in communication with the at least one sensor and the pump, the electronic controller configured to automatically control the pump to maintain the fluid level of the blood in the venous drip chamber by pumping air out of the venous drip chamber with the pump when the at least one sensor detects the fluid level dropping below a first threshold and pumping air into the venous drip chamber with the pump when the at least one sensor detects the fluid level rising above a second threshold.
A disposable cartridge adapted to be inserted into a dialysis system for use in dialysis therapy is provided, comprising an organizer having a plurality of aligning holes configured to mate with alignment pegs on the dialysis delivery system, a tubing set disposed in the organizer, the tubing set comprising, an arterial line portion configured to draw blood from a patient, a venous line portion configured to return blood to the patient, a blood pump portion configured to interface with a blood pump of the dialysis delivery system, a first dialyzer portion configured to carry blood to a dialyzer of the dialysis delivery system, a second dialyzer portion configured to return blood from the dialyzer, first and second saline lines configured to couple a saline source to the tubing set, a venous drip chamber disposed in the organizer and configured to remove air from blood entering the venous drip chamber, the venous drip chamber comprising, first and second ports disposed on a lower portion of the venous drip chamber, the first port being coupled to the venous line portion of the tubing set, the second port being coupled to the arterial line portion of the tubing set.
In some embodiments, the disposable cartridge further comprises a heparin line configured to couple a heparin source to the tubing set.
In one embodiment, the heparin line is coupled to a third port disposed on an upper portion of the venous drip chamber.
In another embodiment, the heparin line is coupled to the venous drip chamber at a non-pulsatile location to prevent back streaming of blood into the heparin line during therapy.
In some embodiments, the non-pulsatile location comprises an air gap in the venous drip chamber.
In other embodiments, the first saline line is attached to the tubing set at a proximal end of the blood pump portion of the tubing set.
In additional embodiments, the second saline line is attached to the tubing set near a proximal end of the arterial line portion of the tubing set.
In some embodiments, the disposable cartridge further comprises an arterial pressure pod disposed along the arterial line portion of the tubing set and configured to mate with an arterial pressure sensor of the dialysis delivery system.
In additional embodiments, the disposable cartridge further comprises a venous transducer connection coupled to the venous drip chamber and configured to mate with a venous pressure sensor of the dialysis delivery system.
A dialysis system is provided, comprising a housing, a water purification system disposed in the housing and configured to prepare water for use in dialysis therapy in real-time using an available water source, a dialysis delivery system disposed in the housing configured to prepare dialysate for dialysis therapy, a dialyzer disposed on or in the housing, a front panel disposed on the housing; the front panel comprising, a plurality of alignment features, a venous level sensor, a blood pump, a plurality of pinch valves, an organizer configured to be mounted to the front panel, the organizer including a plurality of mounting features configured to mate with the plurality of alignment features, the organizer comprising, a tubing set disposed in the organizer, the tubing set comprising, an arterial line portion configured to draw blood from a patient, a venous line portion configured to return blood to the patient, a blood pump portion configured to interface with the blood pump, a first dialyzer portion configured to carry blood to the dialyzer, a second dialyzer portion configured to return blood from the dialyzer, first and second saline lines configured to couple a saline source to the tubing set, a venous drip chamber disposed in the organizer and configured to remove air from blood entering the venous drip chamber, the venous drip chamber comprising, first and second ports disposed on a lower portion of the venous drip chamber, the first port being coupled to the venous line portion of the tubing set, the second port being coupled to the arterial line portion of the tubing set, wherein mounting the organizer to the front panel automatically couples the blood pump portion of the tubing set to the blood pump and the venous drip chamber to the venous level sensor.
The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
This disclosure describes systems, devices, and methods related to dialysis therapy, including a dialysis system that is simple to use and includes automated features that eliminate or reduce the need for technician involvement during dialysis therapy. In some embodiments, the dialysis system can be a home dialysis system. Embodiments of the dialysis system can include various features that automate and improve the performance, efficiency, and safety of dialysis therapy.
In some embodiments, a dialysis system is described that can provide acute and chronic dialysis therapy to users. The system can include a water purification system configured to prepare water for use in dialysis therapy in real-time using available water sources, and a dialysis delivery system configured to prepare the dialysate for dialysis therapy. The dialysis system can include a disposable cartridge and tubing set for connecting to the user during dialysis therapy to retrieve and deliver blood from the user.
Dialysis system 100 can also include a cartridge 120 which can be removably coupled to the housing 106 of the system. The cartridge can include a patient tubing set attached to an organizer, which will be described in more detail below. The cartridge and tubing set, which can be sterile, disposable, one-time use components, are configured to connect to the dialysis system prior to therapy. This connection correctly aligns corresponding components between the cartridge, tubing set, and dialysis system prior to dialysis therapy. For example, the tubing set is automatically associated with one or more pumps (e.g., peristaltic pumps), clamps and sensors for drawing and pumping the user's blood through the tubing set when the cartridge is coupled to the dialysis system. The tubing set can also be associated with a saline source of the dialysis system for automated priming and air removal prior to therapy. In some embodiments, the cartridge and tubing set can be connected to a dialyzer 126 of the dialysis system. In other embodiments, the cartridge and tubing set can include a built-in dialyzer that is pre-attached to the tubing set. A user or patient can interact with the dialysis system via a user interface 113 including a display.
In
In some embodiments, the dialysis system 100 can also include a blood pressure cuff to provide for real-time monitoring of user blood pressure. The system (i.e., the electronic controller of the system) can be configured to monitor the blood pressure of the user during dialysis therapy. If the blood pressure of the user drops below a threshold value (e.g., a blood pressure threshold that indicates the user is hypotonic), the system can alert the user with a low blood pressure alarm and the dialysis therapy can be stopped. In the event that the user ignores a configurable number of low blood pressure alarms from the system, the system can be configured to automatically stop the dialysis therapy, at which point the system can inform the user that return of the user's blood (the blood that remains in the tubing set and dialyzer) back to the user's body is necessary. For example, the system can be pre-programmed to automatically stop therapy if the user ignores three low blood pressure alarms. In other embodiments, the system can give the user a bolus of saline to bring user fluid levels back up before resuming dialysis therapy. The amount of saline delivered to the patient can be tracked and accounted for during ultrafiltration fluid removal.
The dialysis delivery system 104 of
Dialysis can be performed in the dialysis delivery system 104 of the dialysis system 100 by passing a user's blood and dialysate through dialyzer 126. The dialysis system 100 can include an electronic controller configured to manage various flow control devices and features for regulating the flow of dialysate and blood to and from the dialyzer in order to achieve different types of dialysis, including hemodialysis, ultrafiltration, and hemodiafiltration.
The cartridge can be pressed into place on the front panel using these locator pegs 260 to ensure that all the features of the cartridge and tubing set line up and are installed properly with the corresponding features of the front panel 210. In some embodiments, the cartridge can be easily installed with a single hand, and closing the door of the system can seat the cartridge onto the system. As shown in
The pinch clamps can be used for a number of functions before, during, and after dialysis therapy. The pinch clamps 180a-d can be controlled by the electronic controller of the dialysis delivery system. Pinch clamps 180a and 180b can be configured to control the flow of saline from a saline source (such as a saline bag) to the tubing set. In some embodiments, the pinch clamps can be opened and the blood pump 213 can be operated to draw saline into the tubing set to remove air during a priming sequence, to flush impurities from the dialyzer before treatment, and to displace blood back to the user at the end of a treatment. The pinch clamps 180a and 180b can also be used to deliver therapeutic boluses of saline to the user during therapy to maintain blood pressure or adjust electrolytes or fluid levels of the patient. In other embodiments, pumps such as peristaltic pumps may be configured to deliver therapeutic boluses of saline to the user.
Pinch clamps 180c and 180d can be configured to close the arterial and venous lines of the tubing set that connect to the user. They can also be opened and closed multiple times before, during, and after treatment to facilitate actions such as tubing set priming, discarding of priming saline, blood return to the patient, and/or draining the dialyzer after treatment. In one embodiment, the system can incorporate information from venous air sensor 2161, arterial air sensor 216, or other air sensors in the system to close pinch clamps 180c and 180d in the event that air bubbles are found in the lines, particularly in the venous line. In a further embodiment, the system can be configured to remove the detected air bubble(s) by reversing the operation of the blood pump to attempt to clear the air bubble(s) through the venous drip chamber.
Pinch clamps 180a-d can also be actuated to perform a series of self-tests on the tubing set prior to each treatment. The tubing set can be pressurized with the blood pump, and the pressure can be held in the tubing set by closing the pinch valves. The arterial and venous pressure sensors can then be used to look for pressure decay in the tubing set.
Still referring to
The tubing set can further include saline connections 353a and 353b to a saline solution, such as a saline bag, via a saline line 233. As shown in
Flow of fluid, such as blood, through the tubing set 122 will now be described. As described above, the blood pump that interacts with blood pump portion 2167 of tubing set 122 can be a peristaltic pump. The blood pump can operate in two modes of operation. One mode of operation can be a “forward” operating mode of the blood pump that can be used during dialysis therapy to move blood from the patient into the tubing set and back to the patient. Another mode of operation can be a “reverse” operating mode of the blood pump that can be used during a priming sequence to move saline through the tubing set. Fluid flows through the tubing set in the “forward” operating mode in a direction opposite to fluid flowing through the tubing set in the “reverse” operating mode. During dialysis therapy, blood can be drawn from the patient into the tubing set 122 through arterial line 230, due to the blood pump 213 interacting with the tubing set in the “forward” operating mode. Arterial pressure pod 355 can mate with a pressure sensor (arterial pressure sensor 182b of
As shown in
Before treatment, the tubing set can be primed with saline to remove air from the line and prepare the system for dialysis therapy. During a priming sequence, the arterial and venous lines of the tubing set can be connected together to form a continuous loop in the tubing set.
Saline can be drawn into the tubing set through saline connections 353a and/or 353b by activating the blood pump in the “forward” and “reverse” operating modes to cause the blood pump to interact with the tubing set and move saline into the tubing set from the saline source. When the pump operates in this “reverse” operating mode, the saline moves from the saline source into the tubing set and the blood-side of the dialyzer to fill the tubing set and the dialyzer with fluid and remove air from the tubing set via the venous drip chamber. In this “reverse” operating mode, saline flows through the tubing set in the opposite direction of blood flow during dialysis therapy. Thus, the saline flows through the venous drip chamber before flowing through the blood-side of the dialyzer. Air in the venous drip chamber can be monitored with the venous level sensors. Any air in the system can be pushed by the saline into the venous drip chamber.
When the venous level sensors no longer detect any changes to the fluid level in the venous drip chamber, or when air sensors no longer detect air circulating through the tubing set, then the tubing set is primed and ready for treatment. The blood pump can then be operated in the “forward” operating mode to move the saline in the other direction than described above and out of the tubing set. In the “forward” operating mode, the saline travels through the blood-side of the dialyzer before passing through the venous drip chamber and into the patient through venous line 232. In some embodiments, the saline used during the priming sequence is delivered into the patient at the start of dialysis therapy. The amount of saline delivered is tracked and accounted for during dialysis therapy depending on the patient's individual fluid removal requirements. In another embodiment, some or all of the saline is pumped or drained out of the tubing set prior to therapy.
To complete the priming sequence, dialysate can be pumped or moved through the dialysate-side of the dialyzer with a dialysate pump (described below). The dialysate is pumped through the dialysate-side of the dialyzer in the same direction that saline is pumped through the blood-side of the dialyzer. The direction of the saline and dialysate through the dialyzer can be in the direction of bottom to top through the dialyzer, which allows the bubbles to naturally purge through the top of the dialyzer. Thus, the priming sequence of the present disclosure can remove air from both the blood-side and dialysate-sides of the dialyzer without physically manipulating or “flipping” an orientation of the dialyzer, as is required by other conventional systems, since the priming sequence moves fluid through both sides of the dialyzer in the same direction.
During therapy, blood in the tubing set normally passes through the blood-side of the dialyzer in the top down direction. However, during priming, the blood pump can be operated in the “reverse” direction to push saline through the dialyzer in the bottom to top direction to more effectively remove air from the dialyzer. The unique configuration of the tubing set and venous drip chamber allows for the flow of saline in the “reverse” direction through the tubing set because fluid both enters and exits the venous drip chamber at connections on the bottom of the venous drip chamber. Conventional venous drip chambers, in which tubing connections are made at the top and bottom of the venous drip chamber, only allow for fluid flow through the venous drip chamber in one direction. The unique configuration of this disclosure allows for priming of both the blood and dialysate sides of the dialyzer without having to physically flip the dialyzer. Any air generated in the venous drip chamber during priming can be removed by either venting out of the system, or pumping out of the system. In one embodiment, the pinch valves of the system can be periodically actuated to open and close the saline lines of the tubing set depending on the timing of the priming sequence to “bang” bubbles loose in the dialyzer. For example, the pinch valves can be opened and closed every 4-8 seconds to create a pulsing effect of the saline in the lines.
After a priming sequence when saline is in the tubing set, the system can further run self-tests to check for leaks in the tubing set. In one embodiment, the pinch valve on the venous line can be closed with the blood pump running, and air can be pumped into the venous drip chamber. Next, the arterial pinch valve can be closed, and the venous pinch valve can be opened, and the system can check for pressure stabilization. If there is no pressure decay, it can be confirmed that there are no leaks in the system.
At the completion of a dialysis treatment, blood still remains inside the tubing set. The blood pump 213 can be controlled to draw saline into the tubing set to push the remaining blood back into the patient. This blood return mechanism can be highly controlled by the controller and blood pump of the system. For example, during dialysis therapy and blood return, the controller of the system can monitor and track the exact number of revolutions made by the blood pump when the pinch valves that control saline administration are open to know exactly how much saline has been pushed into the tubing set. The blood pump can then be stopped or de-activated when the desired volume of saline is drawn into the tubing set. This allows the system to know exactly how much saline has been used, and how much remains in the saline source or bag. At the end of the dialysis therapy, the amount of blood in the tubing set is known (typically around 250 ml), so the system can precisely meter the correct amount of saline into the tubing set to push the blood back into the user. The anticipated amount of saline to use for blood return (typically 300-600 ml depending on the varying degree of thoroughness of the blood return) can be integrated into the overall fluid removal target for ultrafiltration so that after the blood return the patient target weight is attained. If the needed amount of saline does not remain in the saline source prior to blood return, the system can alert the user that the saline source needs to be refilled or replaced.
In one embodiment, the dialyzer can be flushed prior to beginning dialysis therapy with a patient. In some cases, clinics ignore this labeling and do not flush the dialyzer. The system can be configured to flush the dialyzer with up to 500 ml of saline. As described above, the tubing set is filled with saline during the priming sequence. During this priming, the arterial and venous lines are attached to each other with union joint 256 as illustrated in
The system can also automatically drain any fluid out of the dialyzer after a dialysis treatment. In one embodiment, the blood pump can be run in the reverse direction with the venous line clamped to pull fluid from the dialysate chamber of the dialyzer through the dialyzer microtube walls against gravity through the dialyzer and into the saline source or bag.
Referring to
The water can then flow through one or more carbon filters 110 (shown as CF-1 and CF-2) configured to filter materials such as organic chemicals, chlorine, and chloramines from the water. For example, the carbon filters 110 can include granulated carbon block cartridges having 10-micron filters. The carbon filters can be connected in series with a chlorine sample port 195 positioned in the flow path between the carbon filters. The chlorine sample port can provide a user with access (such as through the front panel of the system) to the flowing water such as for quality control purposes to ensure the total chlorine concentration level of the water is below a certain threshold (e.g., below 0.1 ppm). Additionally, a post-carbon pressure sensor 2179 can be placed after the carbon filter(s) to monitor the fluid pressure in the line after the sediment and carbon filtration. As is also shown in
As shown in
The pressure created by the RO feed pump and a RO concentrate flow restrictor 2181 can control the flow rate of waste to the drain. To ensure that the restriction does not become fouled or plugged, the flow through the RO concentrate flow restrictor can be periodically reversed by actuating valves 180. In addition, to improve filter life and performance, recirculation pumps can be used to increase fluid flow rate in the RO filter housings. This increase in flow rate can serve to reduce a boundary layer effect that can occur near the surface of RO filters where water near the filter membrane may not flow. The boundary layer can create an area with a higher concentration of total dissolved solids that can build up over the surface of the RO filter and may collect and foul the RO filter.
The RO filtration subsystem can include on or more conductivity sensors 196 configured to measure the conductivity of water flowing through the subsystem to measure solute clearance, or per, pressure sensors 198 configured to monitor fluid pressures, and air separators 187 configured to separate and remove air and air bubbles from the fluid. Additionally, the RO filtration subsystem can include a variety of valves 180, including check valves, and fluid pumps for controlling flow through the RO filters and on to the pasteurization subsystem, back through the RO filtration subsystem for further filtration, or to the drain. Water can flow from the RO filtration subsystem to the pasteurization subsystem, described next.
In some embodiments, the HEX 145 can heat water received by the pasteurization subsystem to a temperature of approximately 148 degrees Celsius. The heated water can be held in a dwell chamber of the HEX for a time period sufficient to eliminate and kill bacteria and denature endotoxins. Endotoxins can be described as the carcasses of dead bacteria, characterized by long lipid chains. During water and dialysate preparation, endotoxins can be monitored along with bacteria to judge the purity of the dialysate. Endotoxins in dialysate can cause an undesirable inflammatory response in users. Therefore, it is desirable to minimize the levels of endotoxin in the dialysate. Endotoxins are not readily trapped by the pore size of typical ultrafilters. Instead, the endotoxins are stopped by ultrafilters through surface adsorption which can become saturated with endotoxins to the point that additional endotoxin will start to pass through. Heating endotoxins in superheated water to temperatures as low as 130 degrees C. have been demonstrated to denature endotoxins but the required dwell time is very long (many minutes). At these elevated temperatures, where the water remains in the liquid phase, water which is typically considered a polar solvent and begins to behave like a non-polar solvent to denature the lipid chains of the endotoxin. As the temperature increases to 220 degrees C. or higher, the denaturing of endotoxins occurs in seconds. The HEX of the present disclosure can run at 220 degrees C. or higher while maintaining a pressure (approximately 340 psi for 220 degrees C., but the HEX can withstand pressures of over 1000 psi) that keeps the water in liquid form. In one embodiment, a preferred temperature and pressure range of the HEX is 180-220 degrees C. and 145-340 psi. The water can then be cooled as it exits the dwell chamber. The HEX 145 is a self-contained counterflow heat exchanger that simultaneously heats incoming water and cools outgoing water to reduce energy consumption.
The pasteurization subsystem can include a HEX pump 193 configured to maintain a fluid pressure in the fluid line, to prevent the water from boiling. After the water passes through the HEX 145, a water regulator 197 can reduce the pressure of the water for use in the dialysis delivery system. One or more pressure sensors 182 or temperature sensors 184 can be included for measuring pressure and temperature, respectively, of the water flowing through the pasteurization subsystem. Furthermore, an air separator 187 can further remove air and air bubbles from the water. In one embodiment, a flow restrictor 189 and valve 180 can be used to limit water dumped to the drain when the HEX 145 is heating up. Once the water has passed through the pasteurization subsystem, it has traveled through the entire water purification system and is clean and pure enough to be used in dialysate preparation and delivery by the dialysis delivery system.
After de-aeration and subsequent cooling with the heater 220 to approximately body temperature, acid and bicarbonate concentrates can be volumetrically proportioned into the fluid path by way of concentrate pumps 223 in order to reach the desired dialysate composition. The water and concentrates can be mixed in a series of mixing chambers 224 that utilize a time delay or volumetric mixing instead of in-line mixing to smooth the introduction of fluids.
In one embodiment, the concentrate pumps can run at an elevated rate to push out any air bubbles in the pumping mechanism (e.g., can run at upwards of 30 ml/min compared to ˜7 ml/min during normal operation). Once the dialysate is mixed, a dialysate pump 226 can control the flow of dialysate through the dialysis delivery system. The mixing subsystem 162 can include various pressure sensors 182, temperature sensors 184, and conductivity sensors 196 to monitor the fluid during the dialysate preparation. The conductivity sensors can be used to measure the fluid ionic properties to confirm that the composition is correct.
The flow path within the dialysate delivery system can include one or more bypass or circulation routes that permit circulation of cleaning and/or sterilization fluid through the flow path. The circulation route may be an open flow loop wherein fluid flowing through the circulation route can be dischargeable from the system after use. In another embodiment, the circulation route may be a closed flow loop wherein fluid flowing through the circulation route is not dischargeable from the system.
The blood circuit subsystem can also include a venting circuit 248 adapted to automatically control the fluid level in venous level chamber 361, as described above. The venting circuit can include a pressure compensating pump 250, one or more venting valves 252, and an air filter 254. The venous pressure sensor 182a of the system can also be located in the venting circuit 248. During dialysis therapy, the venous level sensor(s) 181 can monitor a fluid level of blood in the venous drip chamber 361. The electronic controller can receive the fluid level information from the sensor(s) and automatically maintaining the fluid level of the blood in the venous drip chamber by pumping or venting air out of the venous drip chamber with pressure compensating pump 250 and/or venting valves 252 if sensor(s) detect the fluid level dropping below a lower threshold, and by pumping air into the venous drip chamber if the sensor(s) detect the fluid level rising above an upper threshold.
Still referring to
The dialysate pump and used dialysate pump described above can be part of an electronic circuit in communication with the electronic controller of the dialysis system to achieve a controlled ultrafiltration rate, and can also be adjusted to precisely control the addition or removal of fluid to or from the patient.
The dialysate pump and used dialysate pump can be controlled with a high degree of precision to achieve dynamic balancing, periodic balancing, and continuous correction. Referring to
To calibrate the flow of the system, the system can be controlled to enter a bypass mode in which valves 177 are actuated to prevent dialysate flow through the dialyzer. This isolates the patient tubing set on the blood side of the dialyzer from the dialysate flow and creates a closed system for dialysate flow that will not allow ultrafiltration. Whenever the system is in bypass the used dialysate pump can be servoed to maintain constant pressure as measured by pressure sensor 182c, which is positioned between the dialysate pump 226 and used dialysate pump 227. The pump speed of the used dialysate can be adjusted while the pump speed of the dialysate pump is maintained at a constant speed until the pressure measured by pressure sensor 182c stabilizes. Once the pressure is stabilized, the pump speed of the used dialysate pump vs the pump speed of the dialysate pump can be recorded as the pump speed ratio that results in zero ultrafiltration. When the systems exits bypass and returns to dialysis therapy, the used dialysate pump speed can be adjusted based on the desired ultrafiltration rate.
When dialyzer is bypassed, pressure measurements of the dialysate can be made independent of influences or pressures from the blood-side of the dialyzer (e.g., isolated from the blood tubing set). When the dialysate and used dialysate pumps operate at the same rate there is no pressure change at pressure sensor 182c positioned between the two pumps, so there is no flow imbalance between the pumps. However, if the dialysate and used dialysate pumps operate at different rates then a flow imbalance is created between the pumps, and a pressure change representing this flow imbalance can be measured at pressure sensor 182c. In some embodiments, the flow imbalance can be controlled based on the pump strokes of the respective pumps. In other embodiments, the flow imbalance can be controlled based on lookup tables that determine the optimal pump speeds based on the measured venous pressure. The electronic controller of the system can be configured to automatically control the flow of fluid across the dialyzer (i.e., ultrafiltration) by adjusting a pump speed of the used dialysate pump 227 with respect to dialysate pump 226 (or alternatively, of the dialysate pump 226 with respect to used dialysate pump 227) to create a flow imbalance between the dialysate-side and blood-side of the dialyzer. When a flow imbalance is created on the dialysate-side of the dialyzer by operating the pumps 226 and 227 at different speeds, then fluid can flow across the dialyzer membranes from the blood-side to the dialysate-side, and vice versa, to equalize that flow imbalance.
The pump speeds of the dialysate pump 226 and used dialysate pump 227 can be locked in by the system based on a desired rate of ultrafiltration, and valve 180 can be opened for normal operation during dialysis therapy. During therapy, the system can continue to monitor venous pressure on user side at pressure sensor 182a. If the venous pressure changes (e.g., greater than 30mm-Hg mercury in change), the system can be configured to automatically rebalance the pumps with the same technique described above. This allows the pumps to be balanced to achieve the desired amount of fluid transfer through the dialyzer, or alternatively, to achieve no fluid transfer through the dialyzer. In one specific embodiment, the system can detect changes in the venous pressure of the user and automatically adjust the speed of the used dialysate pump 227 based on a look-up table of speeds against venous pressure to maintain ultrafiltration balance in the user. Once the system has been calibrated, the used dialysate pump speed can be modulated to adjust the rate of fluid removal from the patient. In some embodiments, a pump speed of the used dialysate pump can be alternatively increased or decreased relative to the dialysate pump to enable hemodiafiltration (e.g., pushing/pulling fluid onto the patient).
As described above, the water purification system and the dialysate delivery system can both include a variety of pumps, valves, sensors, air separators, air sensors, heat exchangers, and other safety features. All of these features can be controlled electronically and automatically by the electronic controller of the dialysis system.
This application is a continuation of pending U.S. application Ser. No. 14/699,875, filed Apr. 29, 2015, which application claims the benefit of U.S. Provisional Application No. 61/985,779, filed Apr. 29, 2014, titled “Air Removal in Modular Home Dialysis System”, and also claims the benefit of U.S. Provisional Application No. 62/127,155, filed Mar. 2, 2015, titled “Dialysis System”, both of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1662870 | Stancliffe | Mar 1928 | A |
3356360 | Ward | Dec 1967 | A |
3695445 | Esmond | Oct 1972 | A |
3710237 | Watson et al. | Jan 1973 | A |
3762032 | Bowling et al. | Oct 1973 | A |
3809309 | Batista | May 1974 | A |
3827563 | Boe et al. | Aug 1974 | A |
3965008 | Dawson | Jun 1976 | A |
4080295 | Riede | Mar 1978 | A |
4089456 | Toppen et al. | May 1978 | A |
4100068 | Jordan et al. | Jul 1978 | A |
4110220 | Lavender | Aug 1978 | A |
4115273 | Winstead | Sep 1978 | A |
4155157 | Gersbacher | May 1979 | A |
4172033 | Willock | Oct 1979 | A |
4194014 | Hermans et al. | Mar 1980 | A |
4204628 | Houston et al. | May 1980 | A |
4209391 | Lipps | Jun 1980 | A |
4229299 | Savitz et al. | Oct 1980 | A |
4231366 | Schael | Nov 1980 | A |
4267040 | Schal | May 1981 | A |
4293409 | Riede et al. | Oct 1981 | A |
4310416 | Tanaka et al. | Jan 1982 | A |
4317725 | Kume et al. | Mar 1982 | A |
4342651 | Ahrens | Aug 1982 | A |
4476022 | Doll | Oct 1984 | A |
4486303 | Brous | Dec 1984 | A |
4500426 | Ishii et al. | Feb 1985 | A |
4508622 | Polaschegg | Apr 1985 | A |
4536201 | Brorsson et al. | Aug 1985 | A |
4624784 | Lefebvre | Nov 1986 | A |
4647748 | Glassman | Mar 1987 | A |
4661246 | Ash | Apr 1987 | A |
4689108 | Barry, Jr. et al. | Aug 1987 | A |
4756835 | Wilson | Jul 1988 | A |
4769134 | Allan et al. | Sep 1988 | A |
4770787 | Heath et al. | Sep 1988 | A |
4773991 | Aid | Sep 1988 | A |
4786411 | Benattar et al. | Nov 1988 | A |
4827430 | Aid et al. | May 1989 | A |
4869421 | Norris et al. | Sep 1989 | A |
4875619 | Anderson et al. | Oct 1989 | A |
4889635 | Chevallet | Dec 1989 | A |
4894164 | Polaschegg | Jan 1990 | A |
4923613 | Chevallet | May 1990 | A |
5087930 | Roy et al. | Feb 1992 | A |
5092836 | Polaschegg | Mar 1992 | A |
5094749 | Seita et al. | Mar 1992 | A |
5147605 | Tatsuno et al. | Sep 1992 | A |
5227049 | Chevallet | Jul 1993 | A |
5232145 | Alley et al. | Aug 1993 | A |
5236476 | Klick | Aug 1993 | A |
5247434 | Peterson et al. | Sep 1993 | A |
5259961 | Eigendorf | Nov 1993 | A |
5312550 | Hester | May 1994 | A |
5313023 | Johnson | May 1994 | A |
5316676 | Drori | May 1994 | A |
5326476 | Grogan et al. | Jul 1994 | A |
5342326 | Peppel et al. | Aug 1994 | A |
5344392 | Senninger et al. | Sep 1994 | A |
5346472 | Keshaviah et al. | Sep 1994 | A |
5360395 | Utterberg | Nov 1994 | A |
5385623 | Diaz | Jan 1995 | A |
5394732 | Johnson et al. | Mar 1995 | A |
5395351 | Munsch | Mar 1995 | A |
5401238 | Pirazzoli | Mar 1995 | A |
5409612 | Maltais et al. | Apr 1995 | A |
5421208 | Packard et al. | Jun 1995 | A |
5439451 | Collinson et al. | Aug 1995 | A |
5469264 | Shigemori | Nov 1995 | A |
5472614 | Rossi | Dec 1995 | A |
5489385 | Raabe et al. | Feb 1996 | A |
5498253 | Aswad et al. | Mar 1996 | A |
5498338 | Kruger et al. | Mar 1996 | A |
5503624 | Roeher et al. | Apr 1996 | A |
5520640 | Utterberg | May 1996 | A |
5526357 | Jandrell | Jun 1996 | A |
5533996 | Murphey et al. | Jul 1996 | A |
5534328 | Ashmead et al. | Jul 1996 | A |
5536258 | Folden | Jul 1996 | A |
5580460 | Polaschegg | Dec 1996 | A |
5580523 | Bard | Dec 1996 | A |
5582600 | Loh | Dec 1996 | A |
5591016 | Kubota et al. | Jan 1997 | A |
5591344 | Kenley et al. | Jan 1997 | A |
5593581 | Lescoche | Jan 1997 | A |
5595712 | Harbster et al. | Jan 1997 | A |
5609770 | Zimmerman et al. | Mar 1997 | A |
5610645 | Moore et al. | Mar 1997 | A |
5611214 | Wegeng et al. | Mar 1997 | A |
5613663 | Schmidt et al. | Mar 1997 | A |
5615996 | Suzuki et al. | Apr 1997 | A |
5618268 | Raines et al. | Apr 1997 | A |
5618441 | Rosa et al. | Apr 1997 | A |
5620608 | Rosa et al. | Apr 1997 | A |
5623969 | Raines | Apr 1997 | A |
5624572 | Larson et al. | Apr 1997 | A |
5629871 | Love et al. | May 1997 | A |
5630804 | Imada et al. | May 1997 | A |
5643190 | Utterberg | Jul 1997 | A |
5647984 | Hovland et al. | Jul 1997 | A |
5648684 | Bertin et al. | Jul 1997 | A |
5650071 | Brugger et al. | Jul 1997 | A |
5662144 | Lo et al. | Sep 1997 | A |
5685835 | Brugger | Nov 1997 | A |
5689966 | Zess et al. | Nov 1997 | A |
5693008 | Brugger et al. | Dec 1997 | A |
5698916 | Eguchi | Dec 1997 | A |
5711883 | Folden et al. | Jan 1998 | A |
5713850 | Heilmann et al. | Feb 1998 | A |
5725773 | Polaschegg | Mar 1998 | A |
5743892 | Loh et al. | Apr 1998 | A |
5744031 | Bene | Apr 1998 | A |
5749226 | Bowman et al. | May 1998 | A |
5769985 | Kawakami et al. | Jun 1998 | A |
5779833 | Cawley et al. | Jul 1998 | A |
5782575 | Vincent et al. | Jul 1998 | A |
5788099 | Treu et al. | Aug 1998 | A |
5788851 | Kenley et al. | Aug 1998 | A |
5792367 | Mattisson et al. | Aug 1998 | A |
5811062 | Wegeng et al. | Sep 1998 | A |
5813235 | Peterson | Sep 1998 | A |
5851202 | Carlsson | Dec 1998 | A |
5858238 | Mcrea et al. | Jan 1999 | A |
5858239 | Kenley et al. | Jan 1999 | A |
5861555 | Hobro et al. | Jan 1999 | A |
5868930 | Kopf | Feb 1999 | A |
5879316 | Safar et al. | Mar 1999 | A |
5881774 | Utterberg | Mar 1999 | A |
5885456 | Charkoudian et al. | Mar 1999 | A |
5895368 | Utterberg | Apr 1999 | A |
5903211 | Flego et al. | May 1999 | A |
5910138 | Sperko et al. | Jun 1999 | A |
5914033 | Carlsson | Jun 1999 | A |
5921678 | Desai et al. | Jul 1999 | A |
5928177 | Brugger et al. | Jul 1999 | A |
5928180 | Krivitski et al. | Jul 1999 | A |
5932103 | Kenley et al. | Aug 1999 | A |
5932940 | Epstein et al. | Aug 1999 | A |
5938634 | Packard | Aug 1999 | A |
5938938 | Bosetto et al. | Aug 1999 | A |
5951863 | Kruger et al. | Sep 1999 | A |
5951870 | Utterberg | Sep 1999 | A |
5957898 | Jepson et al. | Sep 1999 | A |
5974867 | Forster et al. | Nov 1999 | A |
5976115 | Parris et al. | Nov 1999 | A |
5983947 | Utterberg | Nov 1999 | A |
5984903 | Nadal | Nov 1999 | A |
5993174 | Konishi | Nov 1999 | A |
6003556 | Brugger et al. | Dec 1999 | A |
6010623 | Schnell et al. | Jan 2000 | A |
6024276 | Hirata et al. | Feb 2000 | A |
6032926 | Fuchs | Mar 2000 | A |
6036680 | Horne et al. | Mar 2000 | A |
6039877 | Chevallet et al. | Mar 2000 | A |
6041801 | Gray et al. | Mar 2000 | A |
6044691 | Kenley et al. | Apr 2000 | A |
6048432 | Ecer | Apr 2000 | A |
6058934 | Sullivan | May 2000 | A |
6064797 | Crittendon et al. | May 2000 | A |
6066261 | Spickermann | May 2000 | A |
6071269 | Schnell et al. | Jun 2000 | A |
6074559 | Hahmann et al. | Jun 2000 | A |
6077443 | Goldau | Jun 2000 | A |
6082891 | Schubert et al. | Jul 2000 | A |
6100463 | Ladd et al. | Aug 2000 | A |
6109994 | Cho et al. | Aug 2000 | A |
6113785 | Miura et al. | Sep 2000 | A |
6117115 | Hill et al. | Sep 2000 | A |
6117123 | Barney et al. | Sep 2000 | A |
6121539 | Johnson et al. | Sep 2000 | A |
6123798 | Gandhi et al. | Sep 2000 | A |
6126723 | Drost et al. | Oct 2000 | A |
6126831 | Goldau et al. | Oct 2000 | A |
6129973 | Martin et al. | Oct 2000 | A |
6132616 | Twardowski et al. | Oct 2000 | A |
6139754 | Hartranft et al. | Oct 2000 | A |
6142008 | Cole et al. | Nov 2000 | A |
6143181 | Falkvall et al. | Nov 2000 | A |
6143247 | Sheppard et al. | Nov 2000 | A |
6148635 | Beebe et al. | Nov 2000 | A |
6153102 | Kenley et al. | Nov 2000 | A |
6165149 | Utterberg et al. | Dec 2000 | A |
6165161 | York et al. | Dec 2000 | A |
6167910 | Chow | Jan 2001 | B1 |
6187198 | Utterberg | Feb 2001 | B1 |
6187199 | Goldau | Feb 2001 | B1 |
6192596 | Bennett et al. | Feb 2001 | B1 |
6193462 | Kubota | Feb 2001 | B1 |
6202312 | Rando | Mar 2001 | B1 |
6203522 | Holmberg et al. | Mar 2001 | B1 |
6203535 | Barney et al. | Mar 2001 | B1 |
6212333 | Oik et al. | Apr 2001 | B1 |
6220299 | Arvidsson et al. | Apr 2001 | B1 |
6221040 | Kleinekofort | Apr 2001 | B1 |
6221064 | Nadal | Apr 2001 | B1 |
6223130 | Gray et al. | Apr 2001 | B1 |
6225497 | Becker et al. | May 2001 | B1 |
6234773 | Hill et al. | May 2001 | B1 |
6251279 | Peterson et al. | Jun 2001 | B1 |
6254567 | Treu et al. | Jul 2001 | B1 |
6254754 | Ross et al. | Jul 2001 | B1 |
6258276 | Mika et al. | Jul 2001 | B1 |
6261282 | Jepson et al. | Jul 2001 | B1 |
6277277 | Jacobi et al. | Aug 2001 | B1 |
6280406 | Dolecek et al. | Aug 2001 | B1 |
6284141 | Shaldon et al. | Sep 2001 | B1 |
6302653 | Bryant et al. | Oct 2001 | B1 |
6308721 | Bock et al. | Oct 2001 | B1 |
6309673 | Duponchelle et al. | Oct 2001 | B1 |
6322551 | Brugger | Nov 2001 | B1 |
6323662 | Ferri | Nov 2001 | B2 |
6325774 | Bene et al. | Dec 2001 | B1 |
6329139 | Nova et al. | Dec 2001 | B1 |
6331252 | El Sayyid et al. | Dec 2001 | B1 |
6334301 | Otsap et al. | Jan 2002 | B1 |
6343614 | Gray et al. | Feb 2002 | B1 |
6344033 | Jepson et al. | Feb 2002 | B1 |
6346084 | Schnell et al. | Feb 2002 | B1 |
6347711 | Goebel et al. | Feb 2002 | B1 |
6349170 | Fressinet et al. | Feb 2002 | B1 |
6350260 | Goebel et al. | Feb 2002 | B1 |
6355161 | Shah et al. | Mar 2002 | B1 |
6357332 | Vecchio | Mar 2002 | B1 |
6365041 | Hoadley | Apr 2002 | B1 |
6368505 | Grummert et al. | Apr 2002 | B1 |
6375871 | Bentsen et al. | Apr 2002 | B1 |
6382923 | Gray | May 2002 | B1 |
6387069 | Utterberg | May 2002 | B1 |
6395180 | Chioini et al. | May 2002 | B2 |
6415860 | Kelly et al. | Jul 2002 | B1 |
6416293 | Bouchard et al. | Jul 2002 | B1 |
6423022 | Roeher et al. | Jul 2002 | B1 |
6432309 | Fuke et al. | Aug 2002 | B1 |
6454736 | Ludt et al. | Sep 2002 | B1 |
6454942 | Shintani et al. | Sep 2002 | B1 |
6468056 | Murakoshi | Oct 2002 | B1 |
6477058 | Luebs et al. | Nov 2002 | B1 |
6481982 | Yokomichi | Nov 2002 | B1 |
6485263 | Bryant et al. | Nov 2002 | B1 |
6488842 | Nagaoka | Dec 2002 | B2 |
6488872 | Beebe et al. | Dec 2002 | B1 |
6503062 | Gray et al. | Jan 2003 | B1 |
6514225 | Utterberg et al. | Feb 2003 | B1 |
6514412 | Insley | Feb 2003 | B1 |
6526357 | Soussan et al. | Feb 2003 | B1 |
6527728 | Zhang | Mar 2003 | B2 |
6530262 | Esser | Mar 2003 | B1 |
6536742 | Lotz et al. | Mar 2003 | B2 |
6537506 | Schwalbe et al. | Mar 2003 | B1 |
6544229 | Danby et al. | Apr 2003 | B1 |
6546998 | Oh et al. | Apr 2003 | B2 |
6554789 | Brugger et al. | Apr 2003 | B1 |
6572576 | Brugger et al. | Jun 2003 | B2 |
6572641 | Brugger et al. | Jun 2003 | B2 |
6575927 | Weitzel et al. | Jun 2003 | B1 |
6579241 | Roeher | Jun 2003 | B2 |
6579253 | Burbank et al. | Jun 2003 | B1 |
6581906 | Pott et al. | Jun 2003 | B2 |
6582385 | Burbank et al. | Jun 2003 | B2 |
6592558 | Quah | Jul 2003 | B2 |
6601432 | Ericson et al. | Aug 2003 | B1 |
6602424 | Krämer et al. | Aug 2003 | B1 |
6604908 | Bryant et al. | Aug 2003 | B1 |
6607644 | Apffel, Jr. | Aug 2003 | B1 |
6607697 | Muller | Aug 2003 | B1 |
6616877 | Close et al. | Sep 2003 | B2 |
6616909 | Tonkovich et al. | Sep 2003 | B1 |
6623860 | Hu et al. | Sep 2003 | B2 |
6630068 | Vinci | Oct 2003 | B1 |
6635226 | Tso et al. | Oct 2003 | B1 |
6640611 | Ericson et al. | Nov 2003 | B2 |
6649046 | Chevallet | Nov 2003 | B2 |
6649063 | Brugger et al. | Nov 2003 | B2 |
6652627 | Tonkovich et al. | Nov 2003 | B1 |
6653841 | Koerdt et al. | Nov 2003 | B1 |
6654660 | Singh et al. | Nov 2003 | B1 |
6666840 | Falkvall et al. | Dec 2003 | B1 |
6666909 | Tegrotenhuis et al. | Dec 2003 | B1 |
6672502 | Paul et al. | Jan 2004 | B1 |
6673311 | Sotoyama et al. | Jan 2004 | B1 |
6676621 | Menninger | Jan 2004 | B1 |
6676835 | O'Connor et al. | Jan 2004 | B2 |
6684710 | Chevallet et al. | Feb 2004 | B2 |
6685831 | Dönig et al. | Feb 2004 | B2 |
6686946 | Masuda et al. | Feb 2004 | B2 |
6688381 | Pence et al. | Feb 2004 | B2 |
6695807 | Bell et al. | Feb 2004 | B2 |
6716356 | Collins et al. | Apr 2004 | B2 |
6730233 | Pedrazzi | May 2004 | B2 |
6731216 | Ho et al. | May 2004 | B2 |
6733676 | Takai | May 2004 | B2 |
6736789 | Spickermann | May 2004 | B1 |
6738052 | Manke et al. | May 2004 | B1 |
6743193 | Brugger et al. | Jun 2004 | B2 |
6744038 | Wang et al. | Jun 2004 | B2 |
6746514 | Bedingfield et al. | Jun 2004 | B2 |
6749814 | Bergh et al. | Jun 2004 | B1 |
6767333 | Mller et al. | Jul 2004 | B1 |
6775577 | Crnkovich et al. | Aug 2004 | B2 |
6793831 | Paul et al. | Sep 2004 | B1 |
6797056 | David | Sep 2004 | B2 |
6804991 | Balschat et al. | Oct 2004 | B2 |
6806947 | Ekdahl et al. | Oct 2004 | B1 |
6811707 | Rovatti et al. | Nov 2004 | B2 |
6814547 | Childers et al. | Nov 2004 | B2 |
6814726 | Lauer | Nov 2004 | B1 |
6814859 | Koehler et al. | Nov 2004 | B2 |
6818179 | Edgson et al. | Nov 2004 | B1 |
6821432 | Metzner | Nov 2004 | B2 |
6827698 | Kleinekofort | Dec 2004 | B1 |
6830693 | Govoni et al. | Dec 2004 | B2 |
6838156 | Neyer et al. | Jan 2005 | B1 |
6852231 | Ivansons et al. | Feb 2005 | B2 |
6858137 | Hahmann et al. | Feb 2005 | B2 |
6863867 | Vanden Bussche et al. | Mar 2005 | B2 |
6868309 | Begelman | Mar 2005 | B1 |
6869538 | Yu et al. | Mar 2005 | B2 |
6871838 | Raines et al. | Mar 2005 | B2 |
6877713 | Gray et al. | Apr 2005 | B1 |
6878283 | Thompson | Apr 2005 | B2 |
6880034 | Manke et al. | Apr 2005 | B2 |
6881344 | Vasta et al. | Apr 2005 | B2 |
6889556 | Steger | May 2005 | B2 |
6892781 | Mcherron et al. | May 2005 | B2 |
6903332 | Weiss et al. | Jun 2005 | B2 |
6905479 | Bouchard et al. | Jun 2005 | B1 |
6911262 | Sallavanti et al. | Jun 2005 | B2 |
6913877 | Chaplen et al. | Jul 2005 | B1 |
6929751 | Bowman, Jr. et al. | Aug 2005 | B2 |
6936031 | Caleffi | Aug 2005 | B2 |
6939111 | Huitt et al. | Sep 2005 | B2 |
6939471 | Gross et al. | Sep 2005 | B2 |
6952963 | Delnevo | Oct 2005 | B2 |
6953323 | Childers et al. | Oct 2005 | B2 |
6955655 | Burbank et al. | Oct 2005 | B2 |
6967002 | Edgson et al. | Nov 2005 | B1 |
6974301 | Suzuki et al. | Dec 2005 | B2 |
6976964 | Chevallet et al. | Dec 2005 | B2 |
6979309 | Burbank et al. | Dec 2005 | B2 |
6981522 | O'Connor et al. | Jan 2006 | B2 |
6986428 | Hester et al. | Jan 2006 | B2 |
6989134 | Tonkovich et al. | Jan 2006 | B2 |
6994829 | Whyatt et al. | Feb 2006 | B2 |
7004924 | Brugger et al. | Feb 2006 | B1 |
7014705 | David | Mar 2006 | B2 |
7021148 | Kuhn et al. | Apr 2006 | B2 |
7022098 | Wariar et al. | Apr 2006 | B2 |
7029456 | Ware et al. | Apr 2006 | B2 |
7033498 | Wong | Apr 2006 | B2 |
7033539 | Krensky et al. | Apr 2006 | B2 |
7040142 | Burbank | May 2006 | B2 |
7044432 | Beden et al. | May 2006 | B2 |
7044927 | Mueller et al. | May 2006 | B2 |
7063512 | Haesloop et al. | Jun 2006 | B2 |
7070589 | Lolachi et al. | Jul 2006 | B2 |
7074191 | Bosetto et al. | Jul 2006 | B2 |
7087033 | Brugger et al. | Aug 2006 | B2 |
7087036 | Busby et al. | Aug 2006 | B2 |
7094345 | Gilbert et al. | Aug 2006 | B2 |
7112273 | Weigel et al. | Sep 2006 | B2 |
7114701 | Peppel | Oct 2006 | B2 |
7115206 | Chevallet et al. | Oct 2006 | B2 |
7115228 | Lundtveit et al. | Oct 2006 | B2 |
7118920 | Brophy et al. | Oct 2006 | B2 |
7121815 | Knuth et al. | Oct 2006 | B2 |
7122149 | Li et al. | Oct 2006 | B2 |
7122156 | Bergh et al. | Oct 2006 | B2 |
7125540 | Wegeng et al. | Oct 2006 | B1 |
7131956 | Pirazzoli et al. | Nov 2006 | B1 |
7147615 | Wariar et al. | Dec 2006 | B2 |
7150815 | Ashmead et al. | Dec 2006 | B2 |
7152469 | Milleker et al. | Dec 2006 | B2 |
7163531 | Seese et al. | Jan 2007 | B2 |
7166084 | Utterberg | Jan 2007 | B2 |
7168334 | Drott | Jan 2007 | B1 |
7170591 | Ohishi et al. | Jan 2007 | B2 |
7175697 | Neri | Feb 2007 | B2 |
7186342 | Pirazzoli et al. | Mar 2007 | B2 |
7188151 | Kumar et al. | Mar 2007 | B2 |
7211442 | Gilbert et al. | May 2007 | B2 |
7214312 | Brugger et al. | May 2007 | B2 |
7217108 | Herwig et al. | May 2007 | B2 |
7217364 | Lauer et al. | May 2007 | B2 |
7223262 | Brehm et al. | May 2007 | B2 |
7223338 | Duchamp et al. | May 2007 | B2 |
7232418 | Neri et al. | Jun 2007 | B2 |
7238164 | Childers et al. | Jul 2007 | B2 |
7247146 | Tonelli et al. | Jul 2007 | B2 |
7279134 | Chan et al. | Oct 2007 | B2 |
7291123 | Baraldi et al. | Nov 2007 | B2 |
7306197 | Parrino et al. | Dec 2007 | B2 |
7314061 | Peppel | Jan 2008 | B2 |
7316780 | Fendya et al. | Jan 2008 | B1 |
7337674 | Burbank et al. | Mar 2008 | B2 |
7341568 | Zhang | Mar 2008 | B2 |
7354426 | Young | Apr 2008 | B2 |
7355685 | Scibona et al. | Apr 2008 | B2 |
7378280 | Quake et al. | May 2008 | B2 |
7381195 | Mori et al. | Jun 2008 | B2 |
7393337 | Tonelli et al. | Jul 2008 | B2 |
7402249 | Ikeda | Jul 2008 | B2 |
7469716 | Parrino et al. | Dec 2008 | B2 |
7470265 | Brugger et al. | Dec 2008 | B2 |
7488301 | Beden et al. | Feb 2009 | B2 |
7488447 | Sternby | Feb 2009 | B2 |
7493824 | Brucksch et al. | Feb 2009 | B2 |
7494590 | Felding et al. | Feb 2009 | B2 |
7503908 | Bartholomew | Mar 2009 | B2 |
7507380 | Chang et al. | Mar 2009 | B2 |
7510545 | Peppel | Mar 2009 | B2 |
7517332 | Tonelli et al. | Apr 2009 | B2 |
7517387 | Chevallet et al. | Apr 2009 | B2 |
7520919 | Caleffi | Apr 2009 | B2 |
7537687 | Toyoda et al. | May 2009 | B2 |
7544300 | Brugger et al. | Jun 2009 | B2 |
7551043 | Nguyen et al. | Jun 2009 | B2 |
7559911 | Giannella | Jul 2009 | B2 |
7575562 | Oishi et al. | Aug 2009 | B2 |
7575564 | Childers | Aug 2009 | B2 |
7591449 | Raines et al. | Sep 2009 | B2 |
7603907 | Reiter et al. | Oct 2009 | B2 |
7615035 | Peppel | Nov 2009 | B2 |
7618531 | Sugioka et al. | Nov 2009 | B2 |
7622043 | Sawada et al. | Nov 2009 | B2 |
7632470 | Tabata et al. | Dec 2009 | B2 |
7647834 | O'Mahony et al. | Jan 2010 | B2 |
7648474 | Paolini et al. | Jan 2010 | B2 |
7648476 | Bock et al. | Jan 2010 | B2 |
7648792 | Kaschmitter et al. | Jan 2010 | B2 |
7656527 | Scarpaci | Feb 2010 | B2 |
7661294 | Dam | Feb 2010 | B2 |
7671974 | O'Mahony et al. | Mar 2010 | B2 |
7682328 | Han et al. | Mar 2010 | B2 |
7686778 | Burbank et al. | Mar 2010 | B2 |
7699992 | Sternby | Apr 2010 | B2 |
7708714 | Connell et al. | May 2010 | B2 |
7713226 | Ash et al. | May 2010 | B2 |
7726361 | Bartholomew | Jun 2010 | B2 |
7727220 | Wieslander et al. | Jun 2010 | B2 |
7744553 | Kelly et al. | Jun 2010 | B2 |
7749184 | Cavalcanti et al. | Jul 2010 | B2 |
7758082 | Weigel et al. | Jul 2010 | B2 |
7758547 | Tonelli et al. | Jul 2010 | B2 |
7771379 | Treu | Aug 2010 | B2 |
7771380 | Jönsson et al. | Aug 2010 | B2 |
7775986 | Roeher et al. | Aug 2010 | B2 |
7776219 | Brugger et al. | Aug 2010 | B2 |
7780848 | Kim et al. | Aug 2010 | B2 |
7788038 | Oshita et al. | Aug 2010 | B2 |
7790029 | Dannenmaier et al. | Sep 2010 | B2 |
7794141 | Perry et al. | Sep 2010 | B2 |
7794419 | Paolini et al. | Sep 2010 | B2 |
7801746 | Moll et al. | Sep 2010 | B2 |
7815852 | Sternby | Oct 2010 | B2 |
7824354 | Vinci et al. | Nov 2010 | B2 |
7873489 | Dolgos et al. | Jan 2011 | B2 |
7896831 | Sternby et al. | Mar 2011 | B2 |
7901579 | Brugger et al. | Mar 2011 | B2 |
7913751 | Zwittig | Mar 2011 | B2 |
7918993 | Harraway | Apr 2011 | B2 |
7922899 | Vasta et al. | Apr 2011 | B2 |
7955504 | Jovanovic et al. | Jun 2011 | B1 |
7968250 | Kaschmitter et al. | Jun 2011 | B2 |
8002727 | Brugger et al. | Aug 2011 | B2 |
8012114 | Daniel et al. | Sep 2011 | B2 |
8075509 | Molducci et al. | Dec 2011 | B2 |
8105265 | Demers et al. | Jan 2012 | B2 |
8128822 | Browning et al. | Mar 2012 | B2 |
8137554 | Jovanovic et al. | Mar 2012 | B2 |
8182440 | Cruz et al. | May 2012 | B2 |
8182691 | Stahl | May 2012 | B2 |
8190651 | Treu et al. | May 2012 | B2 |
8192387 | Brugger et al. | Jun 2012 | B2 |
8210049 | Brugger | Jul 2012 | B2 |
8235931 | Burbank et al. | Aug 2012 | B2 |
8236599 | Chang et al. | Aug 2012 | B2 |
8267881 | O'Mahony et al. | Sep 2012 | B2 |
8273245 | Jovanovic et al. | Sep 2012 | B2 |
8293113 | Jönsson et al. | Oct 2012 | B2 |
8293114 | Jönsson et al. | Oct 2012 | B2 |
8298427 | Ficheux et al. | Oct 2012 | B2 |
8323492 | Childers et al. | Dec 2012 | B2 |
8329030 | Childers et al. | Dec 2012 | B2 |
8343085 | Toyoda et al. | Jan 2013 | B2 |
8394046 | Nuernberger et al. | Mar 2013 | B2 |
8414182 | Paul et al. | Apr 2013 | B2 |
8419945 | Browning et al. | Apr 2013 | B2 |
8449487 | Hovland et al. | May 2013 | B2 |
8460228 | Burbank et al. | Jun 2013 | B2 |
8475398 | O'Mahony | Jul 2013 | B2 |
8491518 | Schnell et al. | Jul 2013 | B2 |
8496824 | Remkes et al. | Jul 2013 | B2 |
8501009 | Peterson et al. | Aug 2013 | B2 |
8506536 | Schnell | Aug 2013 | B2 |
8512553 | Cicchello et al. | Aug 2013 | B2 |
8512554 | Yu et al. | Aug 2013 | B2 |
8524086 | Peterson et al. | Sep 2013 | B2 |
8529491 | Beiriger | Sep 2013 | B2 |
8535525 | Heyes et al. | Sep 2013 | B2 |
8603020 | Roger et al. | Dec 2013 | B2 |
8608658 | Burbank et al. | Dec 2013 | B2 |
8647290 | Masala et al. | Feb 2014 | B2 |
8679348 | Burbank et al. | Mar 2014 | B2 |
8685244 | Heyes et al. | Apr 2014 | B2 |
8685251 | Smejtek et al. | Apr 2014 | B2 |
8753515 | Curtis et al. | Jun 2014 | B2 |
8801922 | Wrazel et al. | Aug 2014 | B2 |
8840581 | McGill et al. | Sep 2014 | B2 |
9024746 | Burbank et al. | May 2015 | B2 |
9097370 | Schnell et al. | Aug 2015 | B2 |
9138687 | Peterson et al. | Sep 2015 | B2 |
9220825 | Buckberry | Dec 2015 | B2 |
9220828 | Coates | Dec 2015 | B2 |
9283320 | Brugger et al. | Mar 2016 | B2 |
9480455 | Buckberry | Nov 2016 | B2 |
9482218 | Coates et al. | Nov 2016 | B2 |
9592029 | Buckberry | Mar 2017 | B2 |
9636444 | Burbank et al. | May 2017 | B2 |
9700663 | Burbank et al. | Jul 2017 | B2 |
9835509 | Brugger et al. | Dec 2017 | B2 |
9879807 | Brugger et al. | Jan 2018 | B2 |
20020023879 | Hadden | Feb 2002 | A1 |
20020032398 | Steele et al. | Mar 2002 | A1 |
20020108859 | Wang et al. | Aug 2002 | A1 |
20020108869 | Savtchenko | Aug 2002 | A1 |
20020115200 | Zou et al. | Aug 2002 | A1 |
20020162784 | Kohlheb et al. | Nov 2002 | A1 |
20020187069 | Levin et al. | Dec 2002 | A1 |
20030010717 | Brugger et al. | Jan 2003 | A1 |
20030039169 | Ehrfeld et al. | Feb 2003 | A1 |
20030052429 | Vigna et al. | Mar 2003 | A1 |
20030082066 | Hajaligol et al. | May 2003 | A1 |
20030138349 | Robinson et al. | Jul 2003 | A1 |
20030156991 | Halas et al. | Aug 2003 | A1 |
20030163077 | Kim et al. | Aug 2003 | A1 |
20030183345 | Soberay | Oct 2003 | A1 |
20030220598 | Busby et al. | Nov 2003 | A1 |
20040004589 | Shih | Jan 2004 | A1 |
20040008370 | Keane et al. | Jan 2004 | A1 |
20040012122 | Nagaoka et al. | Jan 2004 | A1 |
20040016700 | Kellam et al. | Jan 2004 | A1 |
20040020286 | Blakley et al. | Feb 2004 | A1 |
20040022691 | Allen et al. | Feb 2004 | A1 |
20040035452 | Ma | Feb 2004 | A1 |
20040035462 | McCarty et al. | Feb 2004 | A1 |
20040072278 | Chou et al. | Apr 2004 | A1 |
20040084370 | Singh et al. | May 2004 | A1 |
20040084371 | Kellam et al. | May 2004 | A1 |
20040086427 | Childers et al. | May 2004 | A1 |
20040125689 | Ehrfeld et al. | Jul 2004 | A1 |
20040157096 | Peterson | Aug 2004 | A1 |
20040158189 | Tonelli et al. | Aug 2004 | A1 |
20040208751 | Lazar et al. | Oct 2004 | A1 |
20040215129 | Edgson et al. | Oct 2004 | A1 |
20040256230 | Yager et al. | Dec 2004 | A1 |
20050006296 | Sullivan et al. | Jan 2005 | A1 |
20050007748 | Callahan et al. | Jan 2005 | A1 |
20050040110 | Felding | Feb 2005 | A1 |
20050070837 | Ferrarini et al. | Mar 2005 | A1 |
20050074834 | Chaplen et al. | Apr 2005 | A1 |
20050082225 | Kreymann | Apr 2005 | A1 |
20050126211 | Drost et al. | Jun 2005 | A1 |
20050129580 | Swinehart et al. | Jun 2005 | A1 |
20050131332 | Kelly et al. | Jun 2005 | A1 |
20050145497 | Gilbert et al. | Jul 2005 | A1 |
20050179748 | Malik et al. | Aug 2005 | A1 |
20050202557 | Borenstein et al. | Sep 2005 | A1 |
20060046113 | Wang et al. | Mar 2006 | A1 |
20060079698 | Joshi et al. | Apr 2006 | A1 |
20060157413 | Bene et al. | Jul 2006 | A1 |
20060174715 | Wehrs et al. | Aug 2006 | A1 |
20060200064 | Gross et al. | Sep 2006 | A1 |
20060266692 | Foster et al. | Nov 2006 | A1 |
20070020400 | Chang | Jan 2007 | A1 |
20070029365 | Paul et al. | Feb 2007 | A1 |
20070119771 | Schukar et al. | May 2007 | A1 |
20070125489 | Paul et al. | Jun 2007 | A1 |
20070128707 | Rorrer et al. | Jun 2007 | A1 |
20070131403 | Vetrovec et al. | Jun 2007 | A1 |
20070158249 | Ash | Jul 2007 | A1 |
20070158268 | Decomo | Jul 2007 | A1 |
20070184576 | Chang et al. | Aug 2007 | A1 |
20070215644 | Otis et al. | Sep 2007 | A1 |
20070278155 | Lo et al. | Dec 2007 | A1 |
20070295651 | Martinez et al. | Dec 2007 | A1 |
20080006040 | Peterson et al. | Jan 2008 | A1 |
20080009780 | Leonard et al. | Jan 2008 | A1 |
20080053842 | Williams et al. | Mar 2008 | A1 |
20080097274 | Neri et al. | Apr 2008 | A1 |
20080108122 | Paul et al. | May 2008 | A1 |
20080108930 | Weitzel et al. | May 2008 | A1 |
20080149563 | Ash | Jun 2008 | A1 |
20080196725 | Mele | Aug 2008 | A1 |
20080200858 | Ichiishi et al. | Aug 2008 | A1 |
20080296226 | Gotch | Dec 2008 | A1 |
20090008331 | Wilt et al. | Jan 2009 | A1 |
20090012452 | Slepicka et al. | Jan 2009 | A1 |
20090038393 | Chaung | Feb 2009 | A1 |
20090076433 | Folden | Mar 2009 | A1 |
20090087326 | Voltenburg et al. | Apr 2009 | A1 |
20090092526 | Miller | Apr 2009 | A1 |
20090095679 | Demers et al. | Apr 2009 | A1 |
20090101549 | Kamen et al. | Apr 2009 | A1 |
20090101576 | Rohde et al. | Apr 2009 | A1 |
20090114595 | Wallenas et al. | May 2009 | A1 |
20090124963 | Hogard et al. | May 2009 | A1 |
20090165366 | Jovanovic et al. | Jul 2009 | A1 |
20090211977 | Miller | Aug 2009 | A1 |
20090230036 | Apel et al. | Sep 2009 | A1 |
20090306573 | Gagner et al. | Dec 2009 | A1 |
20090309835 | Levin et al. | Dec 2009 | A1 |
20090312686 | Sakamoto et al. | Dec 2009 | A1 |
20100018923 | Rohde et al. | Jan 2010 | A1 |
20100022934 | Hogard | Jan 2010 | A1 |
20100051552 | Rohde et al. | Mar 2010 | A1 |
20100078385 | Kawarabata et al. | Apr 2010 | A1 |
20100089807 | Heyes | Apr 2010 | A1 |
20100192686 | Kamen et al. | Aug 2010 | A1 |
20100271296 | Kopychev et al. | Oct 2010 | A1 |
20100292627 | Caleffi et al. | Nov 2010 | A1 |
20100292657 | Fontanazzi et al. | Nov 2010 | A1 |
20100292944 | Howell et al. | Nov 2010 | A1 |
20100321046 | Randall et al. | Dec 2010 | A1 |
20100326914 | Drost et al. | Dec 2010 | A1 |
20110005986 | Kelly et al. | Jan 2011 | A1 |
20110105979 | Schlaeper et al. | May 2011 | A1 |
20110106466 | Furmanski et al. | May 2011 | A1 |
20110132841 | Rohde et al. | Jun 2011 | A1 |
20110186517 | Hedmann et al. | Aug 2011 | A1 |
20110189048 | Curtis et al. | Aug 2011 | A1 |
20110257579 | Rossi et al. | Oct 2011 | A1 |
20110295175 | Felder et al. | Dec 2011 | A1 |
20120029937 | Neftel et al. | Feb 2012 | A1 |
20120065581 | Childers et al. | Mar 2012 | A1 |
20120103902 | Childers et al. | May 2012 | A1 |
20120138533 | Curtis et al. | Jun 2012 | A1 |
20120226236 | Fini et al. | Sep 2012 | A1 |
20120267291 | Coates | Oct 2012 | A1 |
20120292246 | Jovanovic et al. | Nov 2012 | A1 |
20120298580 | Gronau et al. | Nov 2012 | A1 |
20120318740 | Ekdahl et al. | Dec 2012 | A1 |
20130018301 | Weaver et al. | Jan 2013 | A1 |
20130020237 | Wilt et al. | Jan 2013 | A1 |
20130030344 | Gronau et al. | Jan 2013 | A1 |
20130037485 | Wilt et al. | Feb 2013 | A1 |
20130056418 | Kopperschmidt et al. | Mar 2013 | A1 |
20130056419 | Curtis | Mar 2013 | A1 |
20130060233 | O'Connor et al. | Mar 2013 | A1 |
20130092361 | Wrazel et al. | Apr 2013 | A1 |
20130146541 | Weigel et al. | Jun 2013 | A1 |
20130180339 | Brugger | Jul 2013 | A1 |
20130186829 | Callan et al. | Jul 2013 | A1 |
20130206693 | Thys | Aug 2013 | A2 |
20130213890 | Kelly et al. | Aug 2013 | A1 |
20130267883 | Medrano | Oct 2013 | A1 |
20130303963 | Breuch et al. | Nov 2013 | A1 |
20140014580 | Ritter | Jan 2014 | A1 |
20140018727 | Burbank et al. | Jan 2014 | A1 |
20140021111 | Roger et al. | Jan 2014 | A1 |
20140069861 | Browning et al. | Mar 2014 | A1 |
20140072288 | Newell | Mar 2014 | A1 |
20140076058 | Brugger et al. | Mar 2014 | A1 |
20140158589 | Furuhashi | Jun 2014 | A1 |
20140178215 | Baxter et al. | Jun 2014 | A1 |
20140209540 | Smejtek et al. | Jul 2014 | A1 |
20140276424 | Davis et al. | Sep 2014 | A1 |
20140291243 | Curtis et al. | Oct 2014 | A1 |
20140299545 | Wrazel et al. | Oct 2014 | A1 |
20140319035 | Burbank et al. | Oct 2014 | A1 |
20150005699 | Burbank et al. | Jan 2015 | A1 |
20150027951 | Wallace et al. | Jan 2015 | A1 |
20150041377 | Heyes | Feb 2015 | A1 |
20150076053 | Higgitt et al. | Mar 2015 | A1 |
20150129481 | Higgitt et al. | May 2015 | A1 |
20150196702 | Burbank et al. | Jul 2015 | A1 |
20150204733 | Newell et al. | Jul 2015 | A1 |
20150238676 | Giordano et al. | Aug 2015 | A1 |
20150252800 | Buckberry et al. | Sep 2015 | A1 |
20150267821 | Brugger et al. | Sep 2015 | A1 |
20150306294 | Jansson et al. | Oct 2015 | A1 |
20150359973 | Onken et al. | Dec 2015 | A1 |
20160051739 | Buckberry | Feb 2016 | A1 |
20160051743 | Buckberry | Feb 2016 | A1 |
20160084785 | Buckberry | Mar 2016 | A1 |
20160106906 | Buckberry | Apr 2016 | A1 |
20160199558 | Buckberry | Jul 2016 | A1 |
20170290970 | Friederichs et al. | Oct 2017 | A1 |
20170296727 | Burbank et al. | Oct 2017 | A1 |
20170296730 | Soto et al. | Oct 2017 | A1 |
20170312419 | Burbank et al. | Nov 2017 | A1 |
20170326285 | Hogard et al. | Nov 2017 | A1 |
20180104400 | Burbank et al. | Apr 2018 | A1 |
20180126056 | Wrazel et al. | May 2018 | A1 |
20180128688 | Newell et al. | May 2018 | A1 |
20180128698 | Brugger et al. | May 2018 | A1 |
20190022293 | Peterson et al. | Jan 2019 | A1 |
Number | Date | Country |
---|---|---|
2887068 | Apr 2014 | CA |
2930431 | May 2015 | CA |
200951223 | Sep 2007 | CN |
8702995 | Jun 1987 | DE |
69217519 | Jun 1997 | DE |
0165751 | Dec 1985 | EP |
0324922 | Jul 1989 | EP |
0679100 | Nov 1995 | EP |
0796997 | Sep 1997 | EP |
0547025 | Jun 2002 | EP |
1892000 | Feb 2008 | EP |
2319551 | May 2011 | EP |
2535067 | Dec 2012 | EP |
1289738 | Sep 1972 | GB |
59-58002 | Apr 1984 | JP |
60-143803 | Jul 1985 | JP |
H4-35669 | Feb 1992 | JP |
2002143298 | May 2002 | JP |
2002527212 | Aug 2002 | JP |
2007268490 | Oct 2007 | JP |
2007529707 | Oct 2007 | JP |
2012152286 | Aug 2012 | JP |
WO 2013024825 | Feb 2013 | JP |
55-14045 | Jun 2014 | JP |
WO0016916 | Mar 2000 | WO |
WO0025843 | May 2000 | WO |
WO0057935 | Oct 2000 | WO |
WO0240874 | May 2002 | WO |
WO02076529 | Oct 2002 | WO |
WO03076661 | Sep 2003 | WO |
WO2006011009 | Feb 2006 | WO |
WO2006039293 | Apr 2006 | WO |
WO2007073739 | Jul 2007 | WO |
WO2007089855 | Aug 2007 | WO |
WO2008027967 | Mar 2008 | WO |
WO2008106191 | Sep 2008 | WO |
WO2010027435 | Mar 2010 | WO |
WO2010062698 | Jun 2010 | WO |
WO2010085764 | Jul 2010 | WO |
WO2010146343 | Dec 2010 | WO |
WO2014117000 | Jul 2014 | WO |
WO2014124180 | Aug 2014 | WO |
WO2014160370 | Oct 2014 | WO |
WO2015185920 | Dec 2015 | WO |
WO2016030147 | Mar 2016 | WO |
WO2016049542 | Mar 2016 | WO |
WO2016057981 | Apr 2016 | WO |
WO2016057982 | Apr 2016 | WO |
Entry |
---|
Miller et al.; U.S. Appl. No. 14/858,876 entitled “Dialysis machine having a conductivity sensor for determining fluid properties,” filed Sep. 18, 2015. |
Allis et al., “Chapter 16: Nanostructural Architectures from Molecular Building Blocks,” in Handbook of Nanoscience, Engineering, and Technology, 1st Edition (Electrical Engineering Handbook), CRC Press LLC, Boca Raton, FL, Chapter 16 (70 pgs.), Oct. 2002. |
Anglés et al., “Plasticized starch/Tunicin Whiskers Nanocomposite Materials. 2. Mechanical behavior,” Macromolecules, 34, pp. 2921-2931, Mar. 2001. |
California Energy Commission; Development of Supported Polymeric Liquid Membrane Technology for Aqueous MTBE Mitigation, EPRI, Palo Alto, CA, California Energy Commission, Sacramento, CA: Doc. No. 1006577; 70 pgs.; Jul. 2002. |
Demura et al., “Ductile Thin Foil of Ni3Al,” Mechanical Properties of Structural Films, ASTM International Nov. 2000 Symposium (Orlando, FL), pp. 248-261, published Oct. 1, 2001. |
Favier et al.; Nanocomposite materials from latex and cellulose whiskers; Polymers for Advanced Technologies; 6; pp. 351-355; Jan. 1995. |
Federal Energy Technology Center, “Technology Development Through Industrial Partnerships,” (Tech. Dev. Data Sheet), 12 pgs., Sep. 1998. |
Grunert et al., “Progress in the Development of Cellulose Reinforced Nanocomposites,” PMSE Preprints 2000, 82, 232, 2 pgs., Mar. 2000. |
Haas, “Further development of MMW and SMMW platelet feed horn arrays,” Astron. Soc. Pac. Conf. Ser., vol. 75, pp. 99-105, Multi-Feed Systems for Radio Telescopes, Workshop held in Tucson, Arizona, May 16-18, 1994. |
Koeneman et al., “Feasibility of Micro Power Supplies for MEMS,” (pre-publication copy) J. MicroElectoMechanical Sys., 6(4), pp. 355-362, Dec. 1997. |
Morin et al., “Nanocomposites of Chitin Whiskers from Riftia Tubes and Poly (caprolactone),” Macromolecules, vol. 35, pp. 2190-2199, Feb. 2002. |
Nakamura et al., “Research on Pressure Welding Conditions of Various Work Metals (Effects of Contact Pressure, Surface Expansion Ratio and Temperature),” JSME International Journal, Series III 31(3), 612-617, Sep. 1988. |
Nakao et al., “Diffusion Bonding of Intermetallic Compound TiAl,” ISIJ International, 31(10), 1260-1266, Oct. 1991. |
Oddy et al., “Electrokinetic Instability Micromixing,” Anal. Chern., 73(24), pp. 5822-5832, Dec. 2001. |
Omega Engineering Inc.; Load Cell (definition, information); 3 pgs; retrieved from the internet on Jun. 17, 2015 (http://www.omega.com/prodinfo/LoadCells.html). |
Orts et al., “Effect of Fiber Source on Cellulose Reinforced Polymer Nanocomposites,” ANTEC 2004: Conference Proceedings, 62nd Annual Tech. Conference; Chicago, IL, pp. 2427-2431, May 2004. |
Paillet et al., “Chitin Whisker Reinforced Thermoplastic Nanocomposites,” Macromolecules, vol. 34, No. 19, pp. 6527-6530, Sep. 2001. |
Paul et al., “Microlamination for Microtechnology-based Energy, Chemical, and Biological Systems,” ASME IMECE, ASE vol. 39, pp. 45-52, Nashville, Tennessee, Nov. 15-20, 1999. |
Pluess, “Application of Controlled Thermal Expansion in Diffusion Bonding for the High-Volume Microlamination of MECS Devices,” Thesis (MS), Oregon State University, 193 pgs., Sep. 2004. |
Porter et al.; Cost drivers in microlamination based on a high volume production system design; ASME 2002 Conf. Proc.; New Orleans, Louisiana; pp. 267-274; Nov. 17-22, 2002. |
Sharma et al., “The Application of Surface Mount Technology to Multi-Scale Process Intensification,” ASPE, pp. 1-4, Oct. 2003. |
Stroock et al., “Chaotic Mixer for Microchannels,” Science, 295, pp. 647-651, Jan. 2002. |
Thorsen et al.; Microfluidic Large-Scale Integration; Science; 298; pp. 580-584; Oct. 18, 2002. |
Wegeng et al., “Chemical system miniaturization,” Proceedings of the AlChE Spring National Meeting, pp. 1-13, Feb. 1996. |
Hogard et al.; U.S. Appl. No. 14/699,875 entitled “Dialysis System And Methods” filed Apr. 29, 2015. |
Peterson et al.; U.S. Appl. No. 14/808,827 entitled “Fluid Purification System,” filed Jul. 24, 2015. |
Miller; U.S. Appl. No. 14/827,054 entitled “Through-Plate Microchannel Membrane Devices,” filed Aug. 14, 2015. |
Hogard et al.; U.S. Appl. No. 14/821,283 entitled “Dialysis system and methods,” filed Aug. 7, 2015. |
Hogard et al.; U.S. Appl. No. 14/821,307 entitled “Dialysis system and methods,” filed Aug. 7, 2015. |
Hogard et al.; U.S. Appl. No. 14/821,325 entitled “Dialysis system and methods,” filed Aug. 7, 2015. |
Hogard et al.; U.S. Appl. No. 14/821,349 entitled “Dialysis system and methods,” filed Aug. 7, 2015. |
Introtek International; Drip chamber liquid level sensor (sales literature); 2 pages; retrieved from the internet (http://www.introtek.eom/PDFs/1/DDS-14.0_DripDetectSensor.pdf); © Jan. 1, 2009. |
Curtis et al.; U.S. Appl. No. 15/225,712 entitled “Dialysis system with ultrafiltration control,” filed Aug. 1, 2016. |
Hogard et al.; U.S. Pat U.S. Appl. No. 16/295,676 entitled “Dialysis System and Methods,” filed Mar. 7, 2019. |
Ritson et al.; U.S. Pat Appl. # U.S. Appl. No. 16/325,664 entitled “Peritoneal Dialysis System and Methods,” filed Feb. 14, 2019. |
Number | Date | Country | |
---|---|---|---|
20150343133 A1 | Dec 2015 | US |
Number | Date | Country | |
---|---|---|---|
61985779 | Apr 2014 | US | |
62127155 | Mar 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14699875 | Apr 2015 | US |
Child | 14821362 | US |